Novoprotein Scientific Inc. (SHA:688137)
China
· Delayed Price · Currency is CNY 43.10
+2.05 (4.99%)
At close: Mar 10, 2026
Novoprotein Scientific Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2018 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | 2020 - 2018 |
| Net Income | - | -54.42 | 12.84 | 90.72 | 149.01 | Upgrade
|
| Depreciation & Amortization | - | 31.32 | 22.55 | 20.46 | 9.2 | Upgrade
|
| Other Amortization | - | 6.11 | 1.58 | 1.38 | 0.78 | Upgrade
|
| Loss (Gain) From Sale of Assets | - | -0.14 | -0 | -0.04 | -0.03 | Upgrade
|
| Asset Writedown & Restructuring Costs | - | 6.7 | 0.09 | 0.08 | 0.15 | Upgrade
|
| Loss (Gain) From Sale of Investments | - | -2.76 | -17.19 | -4.16 | -0.85 | Upgrade
|
| Provision & Write-off of Bad Debts | - | 2.09 | -1.58 | 1.22 | 3.9 | Upgrade
|
| Other Operating Activities | - | 4.48 | 36.9 | 19.63 | 15.17 | Upgrade
|
| Change in Accounts Receivable | - | 14.64 | 62.8 | -57.73 | -52.73 | Upgrade
|
| Change in Inventory | - | -14.81 | -41.26 | -51.84 | -30.96 | Upgrade
|
| Change in Accounts Payable | - | 10.76 | -8.62 | -15.18 | -29.11 | Upgrade
|
| Change in Other Net Operating Assets | - | 12.63 | 10.48 | 7.01 | 7 | Upgrade
|
| Operating Cash Flow | - | 13.32 | 69.16 | 3.38 | 70.97 | Upgrade
|
| Operating Cash Flow Growth | - | -80.75% | 1948.16% | -95.24% | -27.26% | Upgrade
|
| Capital Expenditures | - | -44.88 | -44.94 | -36.77 | -69.95 | Upgrade
|
| Sale of Property, Plant & Equipment | - | 0 | 0.01 | 0.01 | 0 | Upgrade
|
| Investment in Securities | - | -129.34 | -56.6 | -963.3 | 25 | Upgrade
|
| Other Investing Activities | - | 16.15 | 20.11 | 0.6 | 1 | Upgrade
|
| Investing Cash Flow | - | -158.06 | -81.42 | -999.45 | -43.95 | Upgrade
|
| Long-Term Debt Repaid | - | -26.5 | -17.32 | -11.34 | -4.85 | Upgrade
|
| Total Debt Repaid | - | -26.5 | -17.32 | -11.34 | -4.85 | Upgrade
|
| Net Debt Issued (Repaid) | - | -26.5 | -17.32 | -11.34 | -4.85 | Upgrade
|
| Issuance of Common Stock | - | - | - | 1,742 | 117.67 | Upgrade
|
| Repurchase of Common Stock | - | -10.35 | - | - | - | Upgrade
|
| Common Dividends Paid | - | -35.09 | -35.09 | - | -16.29 | Upgrade
|
| Other Financing Activities | - | -0.63 | -1.52 | 2.51 | -2 | Upgrade
|
| Financing Cash Flow | - | -72.56 | -53.93 | 1,733 | 94.53 | Upgrade
|
| Foreign Exchange Rate Adjustments | - | 0.62 | 0.54 | 2.64 | -0.79 | Upgrade
|
| Net Cash Flow | - | -216.69 | -65.65 | 739.94 | 120.75 | Upgrade
|
| Free Cash Flow | - | -31.57 | 24.22 | -33.39 | 1.02 | Upgrade
|
| Free Cash Flow Growth | - | - | - | - | -98.82% | Upgrade
|
| Free Cash Flow Margin | - | -24.75% | 15.81% | -12.62% | 0.30% | Upgrade
|
| Free Cash Flow Per Share | - | -0.45 | 0.34 | -0.58 | 0.03 | Upgrade
|
| Cash Income Tax Paid | - | 15.27 | 2.63 | 58.63 | 71.24 | Upgrade
|
| Levered Free Cash Flow | - | -21.19 | 0.36 | -68.42 | -40.11 | Upgrade
|
| Unlevered Free Cash Flow | - | -18.95 | 2.6 | -65.89 | -38.99 | Upgrade
|
| Change in Working Capital | - | 19.94 | 13.97 | -125.93 | -106.35 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.